Polymorphism in the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome

Human Reproduction

Volumn 18, Issue 3, 2003, Pages 540-543

  Korhonen, S ^b   Heinonen, Seppo ^a   Hiltunen, M ^a   Helisalmi, S ^c   Hippelainen M ^c   Koivunen, R ^d   Tapanainen, J S ^d   Laakso, M ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b MIKKELI CENTRAL HOSPITAL   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

PCOS; Polymorphism; PPAR

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; TESTOSTERONE;

ACNE; ALLELE; ALOPECIA AREATA; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; GENE FREQUENCY; GENE FUNCTION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

FALLOPIA;

EID: 0037342943     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg128     Document Type: Article

References (21)

1. Altshuler, D., Hirschorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.-C., Nemesh, J., Lane, R.L., Schaffner, S.F., Bolk, S., Brewer, C. et al. (2000). The common PPARγPro12 Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet., 26, 76-80.
2. Beamer, B.A., Negri, C., Yen, C.J., Gavrilova, O., Rumberger, J.M., Durcan, M.J., Yarnall, D.P., Hawkins, A.L., Griffin, C.A., Burns, D.K. et al. (1997). Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene. Biochem. Biophys. Res. Commun., 233, 756-759.
3. Beamer, B., Yen, C., Andersen, R., Muller, D., Elahi, D., Cheskin, L., Andres, R., Roth, J. and Shuldiner, A.R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes, 47, 1806-1808.
4. Deeb, S.S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusito, J., Laakso, M., Fujimoto, W. and Auwerx, J.A. (1998) Pro12Ala substitution in PPAR gamma 2 is associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genet., 20, 284-287.
5. Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
6. Dunaif, A., Scott, D., Finegood, D., Quintana, B. and Whitcomb, R. (1996) The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 81, 3299-3306.
7. Elbrecht, A., Chen, Y., Cullinan, C.A., Hayes, N., Leibowitz, M., Moller, D.E. and Berger, J. (1996) Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun., 224, 431-437.
8. Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440-1447.
9. Franks, S., Gharani, N. and McCarthy, M. (2001) Candidate genes in polycystic ovary syndrome. Hum. Reprod. Update, 7, 405-410.
10. Geffner, M.E., Kaplan, S.A., Berch, N., Golde, D.W., Landaw, E.M. and Chang, R.J. (1986) Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion. Fertil. Steril. 45, 327-333.
11. Hara, M., Alcoser, S.Y., Qaadir, A., Beiswenger, K.K., Cox, N.J. and Ehrmann, D.A. (2002) Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. J. Clin. Endocrinol. Metab., 87, 772-775.
12. Jacob, S., Stumvoll, M., Becker, R., Koch, M., Nielsen, M., Loblein, K., Maerker, E., Volk, A., Renn, W., Balletshofer, B. et al. (2000) The PPARgamma 2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Horm. Metab. Res., 32, 413-416.
13. Legro, R.S., Kunselman, A.R., Dodson, W.C. and Dunaif, A. (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab., 84, 165-169.
14. Miles, P.D., Barak, Y., He, W., Evans, R.M. and Olefsky, J.M. (2000) Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J. Clin. Invest., 105, 287-292.
15. Morin-Papunen, L.C., Vauhkonen, I., Koivunen, R.M., Roukonen, A. and Tapanainen, J.S. (2000) Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum. Reprod., 15, 1266-1274.
16. Mu, Y.M., Yanase, T., Nishi, Y., Waseda, N., Oda, T., Tanaka, A., Takayanagi, R. and Nawata, H. (2000) Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem. Biophys. Res. Commun., 271, 710-713.
17. Mu, Y.M., Yanase, T., Nishi, Y., Takayanagi, R., Goto, K. and Nawata, H. (2001) Combined treatment with specific ligands for PPARgamma: RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell. Endocrinol., 181, 239-248.
18. Nestler, J.E., Barlascini, C.O., Matt, D.W., Steingold, K.A., Plymate, S.R., Clore, J.N. and Blackard, W.G. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027-1032.
19. Peltonen, L., Jalanko, A. and Varilo, T. (1999) Molecular genetics of the Finnish disease heritage. Hum. Mol. Genet., 8, 1913-1923.
20. Pihlajamäki, J., Miettinen, R., Valve, R., Karjalainen, L., Mykkänen, L., Kuusisto, J., Deeb, S., Auwerx, J. and Laakso, M. (2000) The Pro12Ala substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia. Atherosclerosis, 151, 567-574.
21. Stumvoll, M., Wahl, H.G., Loblein, K., Becker, R., Machicao, F., Jacob, S. and Haring, H. (2001) Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma 2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes, 50, 576-881.